Compare THAR & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THAR | TRAK |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.3M | 212.5M |
| IPO Year | 2022 | 1998 |
| Metric | THAR | TRAK |
|---|---|---|
| Price | $4.60 | $10.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 87.6K |
| Earning Date | 11-12-2025 | 02-17-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | N/A | ★ 19.98 |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $23,136,391.00 |
| Revenue This Year | N/A | $8.29 |
| Revenue Next Year | N/A | $24.17 |
| P/E Ratio | ★ N/A | $28.81 |
| Revenue Growth | N/A | ★ 11.05 |
| 52 Week Low | $0.95 | $10.03 |
| 52 Week High | $9.08 | $23.72 |
| Indicator | THAR | TRAK |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 31.44 |
| Support Level | $2.71 | $10.03 |
| Resistance Level | $5.83 | $11.08 |
| Average True Range (ATR) | 0.50 | 0.42 |
| MACD | 0.20 | 0.02 |
| Stochastic Oscillator | 60.74 | 28.36 |
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.